NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / 30 groups in India trying to develop COVID-19 vaccine: Government
    India

    30 groups in India trying to develop COVID-19 vaccine: Government

    30 groups in India trying to develop COVID-19 vaccine: Government
    Written by Siddhant Pandey
    May 29, 2020, 01:03 am 2 min read
    30 groups in India trying to develop COVID-19 vaccine: Government

    About 30 groups in India are trying to develop vaccines against COVID-19, the Principal Scientific Advisor to the Indian government, Prof K. Vijay Raghavan, said on Thursday. Highlighting India's efforts in finding drugs against COVID-19, Raghavan also said the Council for Scientific and Industrial Research (CSIR) and the All India Council for Technical Education (AICTE) have embarked on a drug discovery hackathon.

    'COVID-19 fight to be won through vaccine and drugs'

    Addressing a press briefing on Thursday, NITI Aayog member Dr. VK Paul said, "The fight against coronavirus will be won through vaccine and drugs." Paul is the Chairperson of the Empowered Group-1. Raghavan added, "There are about a total of 30 groups in India, big industry to individual academics, who are trying to develop vaccines, of which around 20 are keeping a good pace."

    'Indian companies/collaborators likely to start human trials in 5-6 months'

    Raghavan said that although developing a vaccine usually takes about a decade, researchers are trying to develop one within a year. He said that Indian companies and collaborators are likely to enter the human trial stage in 5-6 months.

    Hackathon: Students to be trained on computational drug discovery

    For drug discovery, India is focusing on both repurposing existing drugs and developing new ones. Raghavan said the AICTE and CSIR have embarked on a high-end drug discovery hackathon. Under the program, students will be trained with information on how to do computational drug discovery. While India awaits vaccines and drugs, Raghavan suggested focusing on hygiene, decontamination of surfaces, physical distancing, tracking, and testing.

    20 Indian companies producing diagnostic kits

    Raghavan said the RT-PCR test—the gold standard in India—looks for viral genetic material, however, scientists in India and worldwide are trying to develop a test that detects the viral particle's presence. Paul said that at least 20 Indian companies are now producing diagnostic kits. "India will be able to produce 5 lakh indigenous kits daily by July," he added.

    'No fundamental change in properties of virus yet'

    When asked whether there have been any mutations in SARS-CoV-2—the virus that causes COVID-19—Raghavan said no change in the fundamental properties of the virus has been observed till now. On the use of the Hydroxychloroquine drug, Paul reiterated that its "benefits outweigh the risks if any." The World Health Organization has suspended the drug's trials and France recently banned its use for COVID-19 treatment.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    India
    Vaccine
    All India Council for Technical Education (AICTE)
    Council of Scientific and Industrial Research

    India

    RBI unveils new lightweight payment system: Why is it needed Reserve Bank Of India (RBI)
    India records 425 COVID-19 cases, 3 deaths in 24 hours COVID-19
    Weather news: Monsoon likely to be normal, predicts IMD India Meteorological Department (IMD)
    US Defense Secretary Lloyd Austin to visit India next week Lloyd Austin

    Vaccine

    Gurugram: Woman confined herself, son for 3 years fearing COVID-19 Gurugram
    India's 1st nasal COVID-19 vaccine by Bharat Biotech launched COVID-19
    US approves world's first vaccine for honey bees United States of America
    Delhi: Government centers run out of free COVID-19 booster vaccine Delhi

    All India Council for Technical Education (AICTE)

    NIRF Ranking 2022 flags major shortcomings in engineering colleges NIRF
    PCM in class 12 not mandatory for admission in architecture Education
    Engineering seats in India drop to lowest in a decade Employment
    Math, physics no longer mandatory for engineering aspirants, says AICTE Physics

    Council of Scientific and Industrial Research

    Meet scientist Nallathamby Kalaiselvi, India's first woman to head CSIR Tamil Nadu
    COVID-19: DCGI gives approval for phase-2 clinical trials of Colchicine Health & Wellness
    Seropositivity for COVID-19 is less in smokers, vegetarians: CSIR survey Ministry of Health and Family Welfare
    'Feluda' coronavirus test: A game-changer in India's fight against COVID-19? Satyajit Ray

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023